Renabetic Dosage & Drug Information

Concise Prescribing Info Bahasa Concise Prescribing Info

Concise Prescribing Info

Contents

Glibenclamide

Indications/Uses

NIDDM.

Dosage/Direction for Use

Initially ½ tab daily, increasing by ½ tab at intervals of 3-5 days until metabolic control is achieved.

Administration

Should be taken with food.

Contraindications

IDDM, diabetic coma, diabetic metabolic decompensation & severe renal impairment.

Special Precautions

Pregnancy & lactation. Elderly.

Adverse Reactions

GI disturbances & hypersensitivity reactions.

View ADR Monitoring Form

Drug Interactions

Potentiation of hypoglycemic effect w/ alcohol, β-blockers, bezafibrate, biguanides, chloramphenicol, clofibrate, coumarin derivatives, MAOIs, salicylates & tetracyclines. Attenuation & aggravation of metabolic state by laxatives, corticosteroids, nicotinic acid, estrogens, phenothiazine derivatives, saluretics, sympathomimetics, thyroid hormones.

MIMS Class

Antidiabetic Agents

ATC Classification

A10BB01 - glibenclamide ; Belongs to the class of sulfonylureas. Used in the treatment of diabetes.

Regulatory Classification

Presentation/Packing

Form

Renabetic tab 5 mg

Packing/Price

10 × 10's (Rp15,000/boks)

Renabetic

glibenclamide

Manufacturer:

Fahrenheit